BNP Paribas has entered exclusive, preliminary talks to sell its 67% stake in Moroccan subsidiary BMCI to long-standing partner and shareholder Holmarcom Group; the bank said it will provide further details as required by regulators. If the transaction is completed in 2026, BNP Paribas expects a positive impact to its CET1 ratio of roughly +15 basis points, providing a modest capital benefit, though the outcome and timing remain uncertain.
BNP Paribas has entered exclusive, preliminary discussions to sell its 67% stake in Moroccan subsidiary BMCI to the Holmarcom Group, which the bank describes as a long-standing partner and shareholder for the past 30 years. The talks are at an early stage and BNP Paribas stated it will provide further details as required by regulators, leaving outcome, price and timing unresolved. The bank states that, if the transaction is completed in 2026, it would provide an estimated ~+15 basis points boost to BNP Paribas’ common equity tier 1 (CET1) ratio at the time of completion, implying a modest capital benefit rather than a material solvency shift. The limited magnitude of the CET1 effect suggests the operation is primarily a portfolio/ownership reconfiguration rather than a large capital-raising or deleveraging event. From an investor perspective the counterparty being a 30-year local partner reduces integration and execution risk relative to a third-party buyer, but regulatory approvals and the absence of disclosed proceeds create execution and disclosure risk. Market sentiment is mildly positive and cautious, so investors should await definitive terms and regulatory clearances before reassessing BNP Paribas’ capital or earnings trajectory.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
